Injection Every 3 Months to Prevent HIV- Study in San Francisco Enrolling Now
There's a new clinical trial about to get started in SF looking for 25 men or transwomen who are at relatively low risk for HIV to test the safety, tolerability and acceptability of a very long acting (injected once every three months) for Pre-exposure prophylaxis (PrEP). If that sounds like you or someone you know, you can get more info by calling 415-881-7190 (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - June 9, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
HIV-Positive Venezuelans Are Desperately Seeking HIV Medications- Please Help
Even though Venezuela is the third largest oil exporter to the United States and has the largest oil reserves in the world, you would not know that if you visited the country now.
The country's infrastructure is in ruins. State officials have been able to pocket much of the oil revenues and imposed illogical dollar exchange restrictions that are suffocating the economy and its people. The (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - June 6, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Statin Therapy Does Not Improve Cardiovascular Risk for Patients With HIV and Low HDL
The main lipid abnormality of people living with HIV is low high density lipoprotein (HDL). There are 5 subfractions of HDL: 2a, 2b, 3a, 3b, and 3c, from largest (and most effective in cholesterol removal) to smallest (and least effective).
Neither pravastatin nor rosuvastatin changes the distribution of high-density lipoprotein (HDL) subfractions in patients who are HIV-seropositive with (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - June 5, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Bill sponsored by HIV-Positive Legislator Advances Tuesday to Help People with HIV-related Lipodystrophy
The bill was sponsored by Carl Sciortino, one of the nation’s few openly gay and openly HIV-positive legislators. The 35-year-old has since stepped down from the legislature to serve as executive director of the well-respected AIDS Action Committee.
The story of the young, handsome Sciortino is remarkable in and of itself. The child of a self-proclaimed Tea Party conservative, he told (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - June 5, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Aids survivors summit san francisco convened on june 5, 2014 national hiv/aids long-term survivors awareness day
San Francisco, CA — June 5, 2014 is the first-ever National HIV/AIDS Long-Term Survivors Awareness Day (NHALTSAD). On that day, Let’s Kick ASS—AIDS Survivor Syndrome convenes the AIDS Survivors Summit/San Francisco 2014at theSan Francisco LGBT Center on June 5, 2014 from 1:00-9:00 PM. Let’s Kick ASS is bringing together survivors, both HIV-positive and negative, with key Bay Area AIDS (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - June 5, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
New CDC Guidelines: People at Risk for HIV Should Consider Truvada PrEP
Healthcare providers should advise people at "substantial risk" for HIV infection about pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, or Truvada, according to new guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC). This includes HIV negative people in an ongoing sexual relationship with HIV positive partners, gay or bisexual men who have had (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - May 28, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy.
Soft tissue augmentation with PMMA-microspheres for the treatment of HIV-associated buttock lipodystrophy.
Authors
Serra MS, et al.
Journal
Int J STD AIDS. 2014 May 22. pii: 0956462414536878. [Epub ahead of print]
Affiliation
Abstract
BACKGROUND: Progression of lipodystrophy syndrome is a big challenge in HIV treatment. Nowadays, fat loss at the lower part of buttocks has become (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - May 24, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
The untold side of the movie "Dallas Buyers Club"
The movie Dallas Buyers Club brings attention to a little-recognized part of the AIDS activist movement: the desperate struggle to provide anything that might treat the disease when no treatment was available.
AL-721, Compound Q, Peptide T—buyers clubs formed around the country to bring in potential treatments, whether pharmaceutical or botanical, for both the virus and its (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - January 21, 2014 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug
<!--[if gte vml 1]>
<![endif]--><!--[if !vml]--><!--[endif]-->
For Immediate Release
December 9, 2013
Contact: Lynda Dee 410-332-1170 or lyndamdee@aol.com
Fair Pricing Coalition
Condemns Gilead Sciences on
the High Price of New
Hepatitis C Drug Sovaldi™, and
Urges Rapid and Wide Dissemination of Support Program Details for (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - December 9, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Briefing at Congress: The Changing Face of HIV/AIDS in America
Briefing:
The Changing Face of HIV/ AIDS in America
September 18, 2013
Briefing: 9:30-10:30 a.m.
Reception: 10:30-11 :30 a.m.
US Congress Capitol Visitors Center, Room
SVC 212
Hosted by:
AIDS Community Research
Initiative of America (ACRIA)
Services and Advocacy for GLBT Elders (SAGE)
National Hispanic Council on Aging
Human Rights Campaign
Gay Men's Health Crisis
(GMHC) (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - October 9, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Once a Month HIV Medications- Cost Effectiveness
Long-acting antiretroviral (ARV) formulations, now in clinical development, could prolong survival in people with HIV, according to results of a modeling study [1]. But the benefit may hold true only in people with barriers to good adherence. Although long-acting antiretrovirals may not be cheap, the researchers determined they could be "a good value" when used mainly for poorly adherent (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - October 5, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
Once a Month HIV Medications - Cost Effectiveness
Long-acting antiretroviral (ARV) formulations, now in clinical development, could prolong survival in people with HIV, according to results of a modeling study [1]. But the benefit may hold true only in people with barriers to good adherence. Although long-acting antiretrovirals may not be cheap, the researchers determined they could be "a good value" when used mainly for poorly adherent (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - October 5, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
HPV vaccine wears off quickly in HIV-positive women
Women with HIV probably need a booster shot of HPV vaccine within 2 years to maintain efficacy, according to a Canadian study of quadrivalent HPV vaccine (Gardasil) in 136 HIV-positive women.
Antibody response to the vaccine is strong enough at 2 years to protect about 90% of HIV-negative women against HPV [human papillomavirus]. "But in our population, with approximately a year and a half of (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - September 2, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
How HIV Providers Should Prepare for Obamacare
The Affordable Care Act: The name alone is enough to make the eyes of clinicians and patients alike glaze over. Yet the impact of the ACA (colloquially called Obamacare) has the potential to be massive when it comes to access to clinical care for HIV-infected people in the U.S. And with more ACA-related changes on the near horizon, the importance of staying informed has never been greater, (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - August 28, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
What Can We Look Forward to in HIV Cure Research? Conversation With Research Advocate Richard Jefferys
This past March, the 20th Conference on Retroviruses and Opportunistic Infections (CROI) brought an unprecedented flurry of mainstream interest in potential HIV cure strategies. TheBodyPRO.com's Nelson Vergel sat down with leading HIV cure research activist Richard Jefferys for an update on current important aspects, and controversies, in HIV cure research. Jefferys, who coordinates the (Source: Nelson Vergel's HIV Blog)
Source: Nelson Vergel's HIV Blog - August 28, 2013 Category: HIV AIDS Authors: Nelson Vergel Source Type: blogs
